1005409-11-9Relevant academic research and scientific papers
AGONISTS OF THE SPHINGOSINE- 1- PHOSPHATE RECEPTOR (SLP)
-
Page/Page column 66; 114, (2008/06/13)
The invention provides compounds of formula I and formula II, their preparation, a their use as pharmaceutically active immunosuppressive agents for the treatment of autoimmune disorders, organ transplant rejection, disorders associated with an activated immune system, as well as other disorders modulated by lymphopenia or SlP receptors.
CHEMICAL COMPOUNDS
-
Page/Page column 132, (2008/06/13)
The invention provides compounds formula I, their preparation, and their use as pharmaceutically active immunosuppressive agents for the treatment of autoimmune disorders, organ transplant rejection, disorders associated with an activated immune system, a
